Brand names: MIRABEGRON, Myrbetriq
12.1 Mechanism of Action Mirabegron is an agonist of the human beta-3 adrenergic receptor (AR) as demonstrated by in vitro laboratory experiments using the cloned human beta-3 AR. Mirabegron relaxes the detrusor smooth muscle during the storage phase of the urinary bladder fill-void cycle by activation of beta-3 AR which increases bladder capacity. Although mirabegron showed very low intrinsic activity for cloned human beta-1 AR and beta-2 AR, results in humans indicate that beta-1 AR stimulation occurred at a mirabegron dose of 200 mg.
Contraindications
11 documented side effects by frequency
No community discussions found for MIRABEGRON yet.
Every figure on this page links back to its primary source. See data sources for full provenance.
4 available comparisons
Dosage Forms
Tablet
Route
Oral